REVB
REVELATN BIO (REVB)
NASDAQ
$1.01-$0.05 (-4.34%)
Price as of Jun 03, 2026 7:35 PM EDT
  • $4.3M
    Market Cap
  • -90.19%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Income Statement
Total Operating Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Gross Profit
0
N/A
0
N/A
0
N/A
0
N/A
Sales and Marketing Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
-4.1M
+14.51%
-3.5M
-14.40%
-4.1M
-22.90%
-5.4M
N/A
Depreciation and Amortization Expense
27,058
-3.10%
27,923
+11.47%
25,049
+0.004%
25,048
N/A
Total Operating Expenses
9.1M
+13.74%
8.0M
-7.87%
8.7M
-20.32%
10.9M
+251.80%
Operating Profit
-9.1M
+13.74%
-8.0M
-7.87%
-8.7M
-20.32%
-10.9M
+409.92%
Interest Income
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Income and Expense and Net
0
N/A
0
N/A
0
N/A
0
+100.00%
Total Nonoperating Income and Expense
157,165
+102.23%
-7.1M
-182.74%
8.5M
+24,316.25%
34,962
-96.35%
Income before Taxes
-14.9M
+86.39%
-8.0M
-7.87%
-8.7M
-20.32%
-10.9M
+409.92%
Income Taxes
0
N/A
0
N/A
0
N/A
0
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-8.9M
-40.73%
-15.0M
+12,405.64%
-120,254
-98.89%
-10.8M
+408.28%
Net Income from Continuing Operations Applicable to Common
-14.9M
-1.15%
-15.0M
+12,405.64%
-120,254
-98.89%
-10.8M
+408.28%
Basic EPS and Net Income
-23.95
-72.68%
-87.68
+16,443.40%
-0.53
-97.36%
-20.09
+1,617.09%
Diluted EPS and Net Income
-23.95
-72.68%
-87.68
+16,443.40%
-0.53
-97.36%
-20.09
+1,617.09%
Basic Weighted Average Shares
620,785
+261.95%
171,510
-24.99%
228,641
-57.58%
539,037
-70.38%
Diluted Weighted Average Shares
620,785
+261.95%
171,510
-24.99%
228,641
-57.58%
539,037
-70.38%
Balance Sheet
Cash and Cash Equivalents
10.7M
+64.65%
6.5M
-45.80%
12.0M
+128.28%
5.3M
+6,588.97%
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
10.7M
+64.65%
6.5M
-45.80%
12.0M
+128.28%
5.3M
+769.96%
Total Current Assets
10.8M
+64.67%
6.6M
-45.95%
12.1M
+124.40%
5.4M
+6,393.39%
Accumulated Depreciation
98,988
+4.42%
94,802
+41.75%
66,879
+59.88%
41,830
N/A
Property and Plant and Equipment and Net
18,067
-67.93%
56,332
-13.45%
65,084
-27.79%
90,133
N/A
Total Long-Term Assets
30,941
-45.07%
56,332
-58.65%
136,217
-23.17%
177,304
-99.63%
Total Assets
11.6M
+74.91%
6.6M
-45.78%
12.2M
+121.91%
5.5M
-88.63%
Income Taxes Payable
1.4M
+23.93%
1.1M
-2.14%
1.2M
+16.94%
985,497
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Current Liabilities
2.0M
+4.42%
1.9M
-65.61%
5.6M
+25.03%
4.5M
-18.87%
Total Long-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
723,771
+32,124.89%
2,246
-99.93%
3.1M
+4.85%
2.9M
0.00%
Total Liabilities
2.7M
+42.24%
1.9M
-65.61%
5.6M
+25.03%
4.5M
-47.00%
Retained Earnings
-49.4M
+22.01%
-40.5M
+59.05%
-25.5M
+0.47%
-25.3M
+223.94%
Total Stockholders Equity
8.9M
+88.20%
4.7M
-29.17%
6.6M
+531.64%
1.1M
+113.45%
Total Shares Outstanding
1.6M
+203.31%
522,223
+97.41%
264,537
-61.26%
682,882
-62.47%
Cash Flow
Cash from Operating Activities
-8.3M
-54.86%
-18.3M
+151.45%
-7.3M
-35.06%
-11.2M
+1,446.18%
Capital Expenditures
19,171
0.00%
19,171
N/A
N/A
N/A
131,963
N/A
Cash from Investing Activities
-19,171
0.00%
-19,171
N/A
N/A
N/A
-131,963
-100.51%
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
12.5M
-2.93%
12.8M
-8.39%
14.0M
-7.72%
15.2M
+160.92%
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Return on Assets
-97.93%
-38.68%
-159.69%
+11,662.67%
-1.36%
-96.62%
-40.19%
+1,055.87%
Return on Equity
-131.38%
-50.40%
-264.85%
+8,379.67%
-3.12%
-100.98%
319.92%
+914.63%
Revenue Growth
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Current Ratio
5.41
+57.70%
3.43
+57.18%
2.18
+79.49%
1.22
+7,901.32%
Cash Ratio
5.36
+57.68%
3.40
+57.60%
2.15
+82.59%
1.18
+8,153.15%
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow